Northern Trust Corp Keros Therapeutics, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 266,356 shares of KROS stock, worth $2.74 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

266,356

Previous 236,488 12.63%

Holding current value

$2.74 Million

Previous $10.8 Million 43.12%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$41.68 - $58.07 $1.24 Million - $1.73 Million	29,868 Added 12.63%	266,356 $15.5 Million
Q2 2024 Aug 14, 2024	BUY	$44.58 - $66.89 $37,893 - $56,856	850 Added 0.36%	236,488 $10.8 Million
Q1 2024 May 14, 2024	BUY	$41.26 - $70.48 $775,357 - $1.32 Million	18,792 Added 8.67%	235,638 $15.6 Million
Q4 2023 Feb 13, 2024	BUY	$27.12 - $41.05 $107,042 - $162,024	3,947 Added 1.85%	216,846 $8.62 Million
Q3 2023 Nov 13, 2023	BUY	$31.57 - $43.02 $290,949 - $396,472	9,216 Added 4.52%	212,899 $6.79 Million
Q2 2023 Aug 11, 2023	BUY	$37.26 - $51.01 $984,148 - $1.35 Million	26,413 Added 14.9%	203,683 $8.18 Million
Q1 2023 May 15, 2023	BUY	$41.44 - $59.32 $103,848 - $148,655	2,506 Added 1.43%	177,270 $7.57 Million
Q4 2022 Feb 13, 2023	BUY	$39.45 - $51.77 $466,180 - $611,766	11,817 Added 7.25%	174,764 $8.39 Million
Q3 2022 Nov 14, 2022	BUY	$27.8 - $40.12 $345,998 - $499,333	12,446 Added 8.27%	162,947 $6.13 Million
Q2 2022 Aug 12, 2022	BUY	$26.03 - $67.04 $51,643 - $133,007	1,984 Added 1.34%	150,501 $4.16 Million
Q1 2022 May 13, 2022	SELL	$42.12 - $59.36 $238,188 - $335,680	-5,655 Reduced 3.67%	148,517 $8.08 Million
Q4 2021 Feb 08, 2022	BUY	$36.95 - $62.89 $168,196 - $286,275	4,552 Added 3.04%	154,172 $9.02 Million
Q3 2021 Nov 15, 2021	SELL	$29.27 - $43.71 $155,657 - $232,449	-5,318 Reduced 3.43%	149,620 $5.92 Million
Q2 2021 Aug 13, 2021	BUY	$42.4 - $70.11 $1.15 Million - $1.9 Million	27,068 Added 21.17%	154,938 $6.58 Million
Q1 2021 May 12, 2021	SELL	$54.0 - $75.28 $398,034 - $554,888	-7,371 Reduced 5.45%	127,870 $7.87 Million
Q4 2020 Feb 11, 2021	BUY	$36.0 - $82.74 $1.87 Million - $4.29 Million	51,895 Added 62.26%	135,241 $9.54 Million
Q3 2020 Nov 16, 2020	SELL	$27.04 - $62.21 $116,515 - $268,062	-4,309 Reduced 4.92%	83,346 $3.22 Million
Q2 2020 Aug 14, 2020	BUY	$20.08 - $40.39 $1.76 Million - $3.54 Million	87,655 New	87,655 $3.29 Million

Others Institutions Holding KROS

# of Institutions

174

Shares Held

30.8M

Call Options Held

62.7K

Put Options Held

View Full List

About Keros Therapeutics, Inc.

Ticker KROS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,757,000
Market Cap $265M
Description
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...

More about KROS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Keros Therapeutics, Inc. Transaction History